The Valley Desk

NCT05267106 · Interventional trial

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

Overall registry status Terminated

Phase 2

Conditions Adult-type Diffuse Gliomas, Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov